If you would like to receive more information on organising a Corporate Satellite at ESHG 2021 – Virtual, please contact: Ms. Jantie de Roos at Rose INTERNATIONAL.

Please find below an overview of the Corporate Satellites during ESHG 2021 – Virtual. You will first find the LIVE Sessions followed by the On-demand Sessions.

Live Sessions

Saturday, August 28, 2021 – 13.45 – 14.45 hrs

Congenica

Accelerating NGS analysis: automating best clinical practice to provide better outcomes for rare disease patients

  • Saturday, August 28, 13.45- 14.45 hrs

  • CS004

ENGENOME

eVai – ACMG/ClinGen variant interpretation for mendelian diseases and beyond

  • Saturday, August 28, 13.45- 14.15 hrs

  • CS001

Fluidigm

BRIDGES: Breast Cancer Risk After Diagnostic Gene Sequencing

  • Saturday, August 28, 13.45- 14.15 hrs

  • CS003

Samplix

Long-read whole genome analysis of human single cells

  • Saturday, August 28, 13.45- 14.15 hrs

  • CS005

Saturday, August 28, 2021 – 20.00 – 21.30 hrs

DNA Script

Advances in Synthetic Oligo Synthesis to Revamp Your Workflow

  • Saturday, August 28, 20.00 – 21.00 hrs

  • CS008

Sunday, August 29, 2021 – 14.00 – 15.00 hrs

Genomize

Introducing the SEQ Platform: What it brings to the genetic diagnostics field with extended annotation, VUS+ and VUS++ classifications, and genotype/phenotype database features

  • Sunday, August 29, 14.00 – 14.30 hrs

  • CS018

Golden Helix

VSClinical: A Comprehensive NGS Clinical Solution

  • Sunday, August 29, 14.00 – 15.00 hrs

  • CS016

PacBio

Increasing Solve Rates in Rare and Mendelian Disease Research with Long-Read Sequencing

  • Sunday, August 29, 14.00 – 14.30 hrs

  • CS015

PerkinElmer

Advancing Solutions for Single-Cell Genomics

  • Sunday, August 29, 14.00 – 14.30 hrs

  • CS013

Singleron Biotechnologies

Single cell sequencing: a new dimension in cancer diagnosis and treatment

  • Sunday, August 29, 14.00 – 15.00 hrs

  • CS017

varvis®

Automated. Validated. Compliant. Navigate the NGS universe with confidence

  • Sunday, August 29, 14.00 – 15.00 hrs

  • CS014

Sunday, August 29, 2021 – 17.30 – 18.00 hrs

Natera, Inc.

New frontiers in NIPT – Artificial Intelligence and the SMART approach to testing

  • Sunday, August 29, 17.30 – 18.00 hrs

  • CS019

Monday, August 30, 2021 – 12.00 – 13.00 hrs

Blueprint Genetics

Part I: Bringing Clinical Value Through Enhanced Panel-based Testing & mtDNA analysis.

Part II:  Solving Diagnostic Challenges in Difficult-to-Sequence Regions

  • Monday, August 30, 12.00 – 13.00 hrs

  • CS033

NanoString Technologies

A journey of spatial multi-omics in oncology, neuroscience and fibrosis: from areas of interest to data analysis.

  • Monday, August 30, 12.00 – 13.00 hrs

  • CS035

PerkinElmer

A non-PCR and Targeted cfDNA Testing in Clinical Practice

  • Monday, August 30, 12.00 – 12.30 hrs

  • CS031

Roche Sequencing Solutions

Lead the frontline of clinical research with Whole Exome Sequencing

  • Monday, August 30, 12.00 – 13.00 hrs

  • CS034

Twist Bioscience

Accurate Colorectal Neoplasia Detection Through Targeted Bisulfite Sequencing Analysis of Cell-free Circulating Tumor DNA (ctDNA)

  • Monday, August 30, 12.00 – 12.30 hrs

  • CS032

Monday, August 30, 2021 – 15.30 – 16.30 hrs

Beckman Coulter Life Sciences

Next Gen Life Sciences Innovations

  • Monday, August 30, 15.30 – 16.30 hrs

  • CS039

Biomarker Technologies

Performance of Long-read sequencing in resolving human genetic language and BMKCloud based data mining

  • Monday, August 30, 15.30 – 16.00 hrs

  • CS056

Bionano Genomics

Enlightening the dark matter of the genome: Optical Genome Mapping identifies germline retrotransposon insertion in SMARCB1 in two siblings with Atypical Teratoid Rhabdoid Tumor

  • Monday, August 30, 15.30 – 16.30 hrs

  • CS036

OGT

Time to change: Transitioning from arrays to NGS in CLL & ID/DD analysis with confidence

  • Monday, August 30, 15.30 – 16.30 hrs

  • CS037

Oxford Nanopore Techmologies

Advancing human genetics research with nanopore sequencing

  • Monday, August 30, 15.30 – 16.30 hrs

  • CS040

QIAGEN

microRNA profiling for biomarker development and molecular mechanism-of-action studies

  • Monday, August 30, 15.30 – 16.30 hrs

  • CS054

SOPHiA GENETICS

Focusing on what matters most: streamlined secondary and tertiary analyses for clinical exome sequencing

  • Monday, August 30, 15.30 – 16.30 hrs

  • CS038

Monday, August 30, 2021 – 18.45 – 19.45 hrs

Abcam

Understanding physiologically relevant pathways using Abcam’s KO cell lines

  • Monday, August 30, 18.45 – 19.15 hrs

  • CS043

Arima Genomics

Hi-C technology and the role of enhancer rewiring in cancer

  • Monday, August 30, 18.45 – 19.15 hrs

  • CS042

Golden Helix

Supporting the New ACMG Guidelines for NGS based CNVs for Genetic Testing Labs

  • Monday, August 30, 18.45 – 19.45 hrs

  • CS041

SeqOne Genomics

Performance of exome CNVs vs traditional methods in clinical environments

  • Monday, August 30, 18.45 – 19.45 hrs

  • CS055

Monday, August 30, 2021 – 20.15 – 21.45 hrs

DNA Genotek

Saliva RNA for the detection and management of concussion: Discovery, validation and commercialization

  • Monday, August 30, 20.15 – 20.45 hrs

  • CS049

Roche Sequencing Solutions

Opportunities in Precision Oncology: Liquid Biopsy and Interpretation Software

  • Monday, August 30, 20.15 – 21.15 hrs

  • CS044

Tuesday, August 31, 2021 – 14.15 – 15.15 hrs

10x Genomics

Single Cell Multiomics and Spatially Resolved Transcriptomics – Towards a deeper understanding of disease pathogenesis

  • Tuesday, August 31, 14.15 – 14.45 hrs

  • CS053

AstraZeneca and MSD

Optimising germline BRCA testing and beyond

  • Tuesday, August 31, 14.15 – 15.15 hrs

  • CS052

Asuragen

Looking Beyond Copy Number – Using AmplideX® Technology to Support SMA Diagnosis, Screening, and Research

  • Tuesday, August 31, 14.15 – 15.15 hrs

  • CS050

Cytiva

Detection and monitoring of mutations from liquid biopsy – a clinical study

  • Tuesday, August 31, 14.15 – 15.15 hrs

  • CS051

Tuesday, August 31, 2021 – 18.30 – 20.00 hrs

On-demand Sessions

BGI Genomics

Low-Pass Whole Genome Sequencing: a new standard for genome wide association studies at the cost of genotyping arrays

  • CS064

CENTOGENE

Diagnose. Understand. Treat.
The Route to Long-Lasting Medical Solutions

  • CS068

Emedgene

The clinical genome & AI: A streamlined interpretation approach

  • CS069

Fabric Genomics

Rapidly identify pathogenic structural variants (SVs) in whole genome sequence data from 50+ rare disease cases using Fabric’s AI Software

  • CS007

Genomenon

Clinical Perspectives: Optimized Variant Interpretation with the Mastermind Genomic Search Engine

  • CS072

Integrated DNA Technologies

Design and optimization of a new NGS sequencing panel for detecting somatic mutations in hematological malignancies

  • CS076

New England Biolabs

A new era in infection and immunity research –
From immune sequencing to host response to Covid-19 and mRNA vaccine development

  • CS080

Novogene

Sequencing Solutions for your Human Genomics Projects

  • CS084